Literature DB >> 23287104

Evidenced-based comparison of aqueous shunts.

Steven J Gedde1, Joseph F Panarelli, Michael R Banitt, Richard K Lee.   

Abstract

PURPOSE OF REVIEW: This review provides an evidence-based comparison of aqueous shunts in common use. RECENT
FINDINGS: Aqueous shunts are being used with increasing frequency in the surgical management of glaucoma. Recent retrospective studies and prospective clinical trials have compared the outcomes of different shunt designs. Larger end-plate size is associated with greater intraocular pressure (IOP) reduction, but there may be an upper limit beyond which a further increase in plate surface area does not contribute beneficially to pressure control. The biocompatibility of plate material may also influence shunt efficacy. The flow restrictor of the Ahmed glaucoma valve provides an added level of safety by reducing the risk of postoperative hypotony, but this implant also appears to have a higher incidence of bleb encapsulation.
SUMMARY: Several aqueous shunts are commercially available, and all have been shown to be safe and effective in lowering IOP. Studies comparing aqueous shunts have provided valuable information to assist in surgical decision-making in similar patient groups.

Entities:  

Mesh:

Year:  2013        PMID: 23287104     DOI: 10.1097/ICU.0b013e32835cf0f5

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  23 in total

1.  Severe prelenticular membrane formation on the surface of a hydrophilic acrylic intraocular lens after cataract surgery in an eye with an Ahmed valve implant.

Authors:  Yong-Sun Ahn; Jin A Choi
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  Five-year treatment outcomes in the Ahmed Baerveldt comparison study.

Authors:  Donald L Budenz; Keith Barton; Steven J Gedde; William J Feuer; Joyce Schiffman; Vital P Costa; David G Godfrey; Yvonne M Buys
Journal:  Ophthalmology       Date:  2014-10-17       Impact factor: 12.079

Review 3.  Post-operative orbital imaging: a focus on implants and prosthetic devices.

Authors:  Ashok Adams; Kshitij Mankad; Cornelia Poitelea; David H Verity; Indran Davagnanam
Journal:  Neuroradiology       Date:  2014-08-07       Impact factor: 2.804

4.  Intraocular pressure control of a novel glaucoma drainage device - in vitro and in vivo studies.

Authors:  Li-Jun Cui; Di-Chen Li; Jian Liu; Lei Zhang; Yao Xing
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

5.  Membrane-tube-type glaucoma shunt device for refractory glaucoma surgery.

Authors:  Jong Chul Han; Young Hoon Hwang; Byung Heon Ahn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-20       Impact factor: 3.117

6.  Clinical outcomes of amniotic membrane loaded with 5-FU PLGA nanoparticles in experimental trabeculectomy.

Authors:  Fang Hu; Xiang-Yun Zeng; Zhao-Lian Xie; Lin-Lin Liu; Liang Huang
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

7.  Surgical treatment of neovascular glaucoma: a systematic review and meta-analysis.

Authors:  Zakhar Shchomak; David Cordeiro Sousa; Inês Leal; Luís Abegão Pinto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-02-06       Impact factor: 3.117

8.  A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.

Authors:  Joseph F Panarelli; Michael R Banitt; Steven J Gedde; Wei Shi; Joyce C Schiffman; William J Feuer
Journal:  Ophthalmology       Date:  2015-12-30       Impact factor: 12.079

9.  Impact of same-session trabectome surgery on Ahmed glaucoma valve outcomes.

Authors:  Hamed Esfandiari; Tarek Shazly; Priyal Shah; Kiana Hassanpour; Pooya Torkian; Mehdi Yaseri; Nils A Loewen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-30       Impact factor: 3.117

10.  Laser Activated Flow Regulator for Glaucoma Drainage Devices.

Authors:  Jeffrey L Olson; Raul Velez-Montoya; Ramanath Bhandari
Journal:  Transl Vis Sci Technol       Date:  2014-11-03       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.